The Team
Greg Donaldson
Founder / Psychotherapist / Psychedelic Guide / Facilitator
Greg Donaldson is a UKCP psychosynthesis psychotherapist and supervisor based in Brighton. He has a passion for psychosynthesis and working archetypally, helping clients to come into more acceptance of themselves and their relationships.
Greg trained at the Psychosynthesis Trust where he gained his MA in psychosynthesis psychotherapy and went on to teach applied psychosynthesis at the trust from 2021-2024.
Greg has an interest in integrating peak experiences and has worked as a psychedelic guide for the phase 2 trials at Imperial College for patients with treatment resistant depression. He then went on to co-facilitate the first London psychedelic integration group, and then became a co-founder of the Brighton psychedelics integration group. He also worked the Synthesis institute throughout 2019/20 offering an online integration space that followed a nature-based programme designed by Rosalind Watts.
In 2023 Greg headed up a team to develop an integration protocol for Hammersmith Medicines Research Centre, where patients were being administered Ibogaine in clinical trials.
Greg has a private practice in Brighton & online and works with clients seeking to prepare & integrate their psychedelic experiences.
Michelle Baker Jones
Therapist/ Psychedelic Guide/ Speaker/ Facilitator
Michelle is an integrative psychotherapeutic counsellor based in London, where she has a private practice. She has been a member of Imperial College's Psychedelic Research Group since 2015. Michelle was a lead guide on Imperial College’s randomised controlled trial (Psilodep 2) comparing psilocybin to escitalopram in the treatment of depression.
She has recently been working as a lead therapist for Small Pharma’s clinical trials with DMT-assisted therapy for depression. This was originally a collaboration between Small Pharma and Imperial College London. She co-designed the Beckley Academy Foundations to Psychedelic-Assisted Therapy training course. Michelle has contributed to the development of a therapist training programme for the DMT trials, having co-produced a psychedelic therapy framework for working with DMT.
Michelle offers individual psychedelic integration for people who are struggling to process psychedelic experiences. She co-facilitates the psychedelic integration specialist interest group for The Institute of Psychedelic Therapy, drawing on her experience of facilitating integration groups over the past five years.
Hattie Wells
Psychedelic Guide / Speaker/ Facilitator
Hattie Wells is a psychedelic practitioner, ethnobotanist, activist and director of Breaking Convention. As one of the first people in the UK to facilitate ibogaine treatments for interrupting addiction, she has been dedicated to researching and disseminating information about the therapeutic potential of ibogaine and other psychedelics for over twenty years.
She has worked with organisations such as the Beckley Foundation, Transform Drug Policy Foundation and ICEERS, in an effort to support psychedelic science initiatives, promote harm reduction, challenge the needless criminalisation of people who use certain drugs, and create a path forward that minimises the risks and maximises the benefits of the use of psychedelics and plant medicines. She consults for various organisations in the psychedelic space (non-profit and for-profit), and is currently working as a psychedelic guide for clinical trials. She lives in Bristol with her two daughters.
Dr Graham Campbell
Psychiatrist / Speaker / Facilitator
Graham worked in NHS mental health services for 15 years; eight of those years as a consultant psychiatrist in a psychiatric hospital in Brighton & Hove. He has an MSc in Neuroscience from Kings College London and trained with the Imperial College Psychedelic Research Group to work as an assistant guide on the psilocybin vs escitalopram depression trial (Psilodep 2).
He has helped organise and facilitate psychedelic integration groups in Brighton since 2019 and has worked as an associate editor for a special edition of Frontiers in Psychiatry on the potential clinical application of psychedelics. He is a member of the Advisory Council with The Institute of Psychedelic Therapy and co-chairs Academic Circle groups for IPT members/affiliates.
In 2020, he left the NHS to work full-time as a trial psychiatrist and psychedelic guide for Small Pharma’s DMT-assisted psychotherapy trials for depression. Phase I and Phase IIa trials have now been completed. Graham has contributed to the development of a therapist training programme for the DMT trials, having co-produced a psychedelic therapy framework for working with DMT.
He also works as an advisor and writer for Lumenate; a company that turns your phone into a strobe light for inducing altered states of consciousness. He was a mentor for the MIND Foundation augmented psychotherapy training programme and currently works in private psychiatry practice in Brighton.
Dr Rosalind Watts
Clinical Psychologist / Speaker / Facilitator
Dr Watts is a clinical psychologist, a mother, and a nature lover. Her work as the Clinical Lead for Imperial College London’s psilocybin trial has made her one of the most prominent voices and minds in the field of psychedelic research.
Dr Watts has been named as one of the 50 Most Influential People in Psychedelics as well as one of the top Top 16 Women Shaping the Future of Psychedelics. However, what sets Dr Watts apart is her focus on integration, harm-reduction and inclusion in the psychedelic space.
Dr Watts builds tools and structures to foster connectedness after psychedelic experiences, finding inspiration for their design from nature. Through all her work, Rosalind's main learning has been that safe and effective use of psychedelics requires substantial integration support. As a result, she co-founded the UK's first psychedelic integration group, and in 2022 launched ACER (‘Accept, Connect, Embody, Restore’) Integration - a global online integration community where participants follow a 13-month process together to connect more deeply to the self, others, and nature.
Tom Shutte
Psychotherapist / Speaker / Facilitator
Tom Shutte is a psychotherapist and supervisor working in private practice and as a clinical research therapist. Tom first became interested in psychosynthesis after reading Assagioli’s writings on spiritual emergency in his early 20’s. He trained at the Trust to MA level and wrote his dissertation on the use of psychosynthesis as a method for the integration of ayahuasca induced psychedelic experiences.
He is a contributing author to the Manual of Psychedelic Support (MAPS) and was previously Clinical Lead at Wavepaths, a company specialising in personalised music for psychedelic therapy. He is currently lead therapist working on research trials in the UK with 5-MeO-DMT, Methylone and Psilocybin.